Agios Pharmaceuticals AGIO Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's cash ratio?
- Agios Pharmaceuticals (AGIO) reported cash ratio of 1.9× in Q1 2026.
- How has Agios Pharmaceuticals's cash ratio changed year-over-year?
- Agios Pharmaceuticals's cash ratio increased by 28.0% year-over-year, from 1.5× to 1.9×.
- What is the long-term trend for Agios Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's cash ratio has grown at a -4.3% compound annual growth rate (CAGR), from 1.4× to 1.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.